Clinical Trial Update: Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating melphalan followed by peripheral stem cell transplantation in patients with multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Alkeran (melphalan)

Snippet

Sponsor: Northwestern University | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 3 | Status: COMPLETED